OKYO Pharma
Biotechnology Research
London, City of, United Kingdom
6 employees
- Employees
- 6
- Contacts
- 2
- Emails
- 2
- Phones
- 2
OKYO Pharma Overview
- Headquarters
- London, City of, United Kingdom
- Website
- www.okyopharma.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2018
- Funding
- 1.9M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About OKYO Pharma
OKYO Pharma focuses on: A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis. An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations.
OKYO Pharma Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 2
- 50.0% coverage
OKYO Pharma Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Paul Spencer | Business Development Leader - Driving |
View
|
|
| Raj Patil, Ph.d. | Chief Scientific Officer at Okyo Pharma | New York, United States |
Email
Phone
|
| Najim Hossain | Business Owner at Okyo Pharma | Bogra, Rajshahi, Bangladesh |
View
|
| Bernard Denoyer | Retired SVP Finance/cfo/board Member | New London County, Connecticut, United States |
Email
Phone
|
Employees by Management Level
Executive
3 profiles
Individual contributor
1 profile
Compare Similar Companies to OKYO Pharma
Glaukos Corporation
Medical Equipment Manufacturing
Apellis Pharmaceuticals
Biotechnology Research
Ora
Pharmaceutical Manufacturing
LENZ Therapeutics
Pharmaceutical Manufacturing
Neurotech Pharmaceuticals, Inc.
Biotechnology Research
Longeveron
Biotechnology
Eyenovia, Inc.
Pharmaceutical Manufacturing
Alzamend Neuro
Biotechnology Research
Tiziana Life Sciences
Biotechnology Research
Kaerus Bioscience Ltd.
Biotechnology Research